Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/18/2003US20030232058 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/18/2003US20030232056 Compositions and methods for the therapy and diagnosis of ovarian cancer
12/18/2003US20030232054 Novel nucleic acids and polypeptides
12/18/2003US20030232047 Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof
12/18/2003US20030232037 Immunology, gene therapy
12/18/2003US20030232036 Alphavirus RNA replicon systems
12/18/2003US20030232035 Capable of expressing a heterologous sequence in target cells; vaccines
12/18/2003US20030232032 Drug design
12/18/2003US20030232022 P. gingivalis antigenic composition
12/18/2003US20030232014 Mass spectrometry-based procedure for detection of amino acid modifications, such as phosphorylation; drug discovery
12/18/2003DE20121968U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/18/2003DE20121967U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/18/2003DE20121963U1 Nukleinsäuren für die Diagnose von mit Entwicklungsgenen assoziierten Krankheiten Nucleic acids for diagnosis of diseases associated with developmental genes
12/18/2003DE20121961U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/18/2003CA2790348A1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
12/18/2003CA2590618A1 Method of treating cancer using kinase inhibitors
12/18/2003CA2489906A1 Androgen receptor coregulators
12/18/2003CA2489198A1 Cancer-linked gene as target for chemotherapy
12/18/2003CA2489195A1 Anti-addl antibodies and uses thereof
12/18/2003CA2489186A1 Chemical synthesis of reagents for peptide coupling
12/18/2003CA2489153A1 Modified byrodin 1 with reduced immunogenicity
12/18/2003CA2489083A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor
12/18/2003CA2489077A1 Method and system for multi-stage isoelectric focussing
12/18/2003CA2489054A1 Chromoprotein
12/18/2003CA2489053A1 Chromoprotein
12/18/2003CA2489050A1 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
12/18/2003CA2488937A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
12/18/2003CA2488932A1 Transgenic mammals expressing polyglutamine
12/18/2003CA2488883A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor
12/18/2003CA2488773A1 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/18/2003CA2488744A1 Compositions and methods for the use of bcl-2 transfected neurons
12/18/2003CA2488682A1 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
12/18/2003CA2488629A1 Cancer-linked gene as target for chemotherapy
12/18/2003CA2488621A1 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
12/18/2003CA2488558A1 Prevention and reduction of blood loss
12/18/2003CA2488497A1 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003CA2488382A1 Methods and compositions for detecting cancers
12/18/2003CA2488360A1 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
12/18/2003CA2488358A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
12/18/2003CA2488347A1 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
12/18/2003CA2488246A1 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
12/18/2003CA2488218A1 Therapeutic epitopes and uses thereof
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487831A1 Immunogenic compositions
12/18/2003CA2487438A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators
12/18/2003CA2487418A1 Metalloproteinase inhibitors
12/18/2003CA2487416A1 Methods and compositions for treating and diagnosing diabetes
12/18/2003CA2487133A1 Use of il-21 in cancer and other therapeutic applications
12/18/2003CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2486270A1 Vegfr modulating agents and methods for liver growth and liver protection
12/18/2003CA2486118A1 Flexible vaccine assembly and vaccine delivery platform
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
12/18/2003CA2480351A1 Improvements in and relating to a method of dna testing for mycobacterium paratuberculosis strains
12/18/2003CA2473321A1 Flavivirus vaccines
12/17/2003EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
12/17/2003EP1371729A2 Use of ttf3 ligands for the diagnosis and therapy of cancer
12/17/2003EP1371728A1 Gene encoding adseverin
12/17/2003EP1371724A1 Promoters
12/17/2003EP1371664A1 Wti modified peptide
12/17/2003EP1371663A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process
12/17/2003EP1371662A1 Novel variant of the cellular receptor LXR alpha
12/17/2003EP1371661A1 Variants of the Constitutive Activated of Retinoid acid response receptor (CAR) in its ligand binding domain (LBD)
12/17/2003EP1371660A1 Vaccine
12/17/2003EP1371377A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/17/2003EP1371375A1 Vaccine to protect animals against leishmania
12/17/2003EP1371373A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
12/17/2003EP1370685A2 Diagnosis of diseases associated with dna repair
12/17/2003EP1370684A2 Polynucleotides related to colon cancer
12/17/2003EP1370679A2 Methods of making and uses of compositions that modulate intronic region-encoded protein function
12/17/2003EP1370678A2 Methods and reagents for regulating apoptosis
12/17/2003EP1370676A2 Mouse cytokine receptor
12/17/2003EP1370675A1 Novel nucleic acids and polypeptides
12/17/2003EP1370666A2 Genetic immunisation against cervical carcinoma
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370660A2 Pepsin-sensitive modified bacillus thuringiensis insecticidal toxin
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370658A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
12/17/2003EP1370657A2 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
12/17/2003EP1370656A2 Novel human ion channel protein and polynucleotides encoding the same
12/17/2003EP1370655A2 Secreted human proteins
12/17/2003EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins
12/17/2003EP1370651A1 70 human secreted proteins
12/17/2003EP1370649A1 Protein c variants
12/17/2003EP1370589A2 Rationally designed antibodies
12/17/2003EP1370587A2 Antiangiogenic peptides derived from endostatin
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370582A1 Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms)
12/17/2003EP1370581A2 Recombinant p. vivax merozoite protein-1 p42 vaccine
12/17/2003EP1370580A2 A new essential downstream component of the wingless signalling pathway
12/17/2003EP1370579A1 Matrix gene expression in chondrogenesis
12/17/2003EP1370578A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening
12/17/2003EP1370577A2 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
12/17/2003EP1370576A1 Methods and compositions for modulating tumor suppression
12/17/2003EP1370574A1 Sequentially arranged streptavidin-binding modules as affinity tags
12/17/2003EP1370572A2 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
12/17/2003EP1370299A1 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
1 ... 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 ... 2916